Results

Total Results: 446 records

Showing results for "onset".

1. Masks-Surveillance-2-Appendix-Table-A-2 (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/masks-surveillance-2-appendix-table-a-2.xlsx
   March 01, 2020 - the time by all family members (including index case) vs. no family members before index case illness onset … at least one family member (including index case) vs. no family members prior to index case illness onset … time by at least one family member or index case vs. no family members prior to index case illness onset … family members wore mask (N95, surgical, or cloth) all the time vs. never after index case illness onset … 0.30 (0.11 to 0.82) • Sometimes vs. never: 1.15 (0.11 to 0.82) Mask use after index case symptom onset

2. Masks-Appendix-Table-B-2-Surveillance-Report (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/Masks-appendix-table-b-2-surveillance-report.xlsx
   March 01, 2020 - the time by all family members (including index case) vs. no family members before index case illness onset … at least one family member (including index case) vs. no family members prior to index case illness onset … time by at least one family member or index case vs. no family members prior to index case illness onset … family members wore mask (N95, surgical, or cloth) all the time vs. never after index case illness onset … 0.30 (0.11 to 0.82) • Sometimes vs. never: 1.15 (0.11 to 0.82) Mask use after index case symptom onset

3. Management of Insomnia Disorder in Adults: Current State of the Evidence (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/insomnia_clinician.pdf
   August 01, 2017 - Outcome measures include: �� Sleep outcome measures: These assess specific sleep parameters (sleep-onset … latency, time awake after sleep onset, total sleep time, and sleep efficiency) or sleep quality. … latency and total sleep time (���) May reduce time awake after sleep onset (���) May improve ( … (���) (���) May improve sleep onset latency (���) Zolpidem ER May improve (���) May improve some … latency, total sleep time, time awake after sleep onset, sleep efficiency, and sleep quality.

4. Diagnosis and Management of Obsessive Compulsive Disorders in Children (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/ocd-protocol.pdf
   August 15, 2023 - adolescents) experience OCD.2 An international study of patients with OCD reported that 21% had symptom onset … in childhood (≤12 years) and 36% had symptom onset during adolescence (13-17 years).3 Early identification … Childhood, adolescent and adult age at onset and related clinical correlates in obsessive-compulsive … Prevalence of Acute-Onset Subtypes in Pediatric Obsessive- Compulsive Disorder. … Prevalence of Acute-Onset Subtypes in Pediatric Obsessive-Compulsive Disorder.

5. Appendix Table B-1. RCTs of Masks (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/masks-appendix-table-b-1-version-1.xlsx
   April 09, 2020 - C Index cases Symptom onset to randomization interval 12-24 hrs: 46% vs. 52% vs. 59% Randomization to … C when restricted to contacts of index cases receiving intervention within 36 hours of symptom onset … C when restricted to contacts of index cases receiving intervention within 36 hours of symptom onset … C when restricted to contacts of index cases receiving intervention within 36 hours of symptom onset … : 0% vs. 0% vs. 0% Household contacts Vaccination at least 14 days prior to index case symptom onset:

6. Masks-Surveillance-2-Appendix-Table-A-1 (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/masks-surveillance-2-appendix-table-a-1.xlsx
   April 09, 2020 - C Index cases Symptom onset to randomization interval 12-24 hrs: 46% vs. 52% vs. 59% Randomization to … C when restricted to contacts of index cases receiving intervention within 36 hours of symptom onset … C when restricted to contacts of index cases receiving intervention within 36 hours of symptom onset … C when restricted to contacts of index cases receiving intervention within 36 hours of symptom onset … : 0% vs. 0% vs. 0% Household contacts Vaccination at least 14 days prior to index case symptom onset:

7. Masks-Appendix-Table-B-1-Version-2 (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/masks-appendix-table-b-1-version-2.xlsx
   April 09, 2020 - C Index cases Symptom onset to randomization interval 12-24 hrs: 46% vs. 52% vs. 59% Randomization to … C when restricted to contacts of index cases receiving intervention within 36 hours of symptom onset … C when restricted to contacts of index cases receiving intervention within 36 hours of symptom onset … C when restricted to contacts of index cases receiving intervention within 36 hours of symptom onset … : 0% vs. 0% vs. 0% Household contacts Vaccination at least 14 days prior to index case symptom onset:

8. Masks-Appendix-Table-B-1-Surveillance-Report (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/Masks-appendix-table-b-1-surveillance-report.xlsx
   April 09, 2020 - C Index cases Symptom onset to randomization interval 12-24 hrs: 46% vs. 52% vs. 59% Randomization to … C when restricted to contacts of index cases receiving intervention within 36 hours of symptom onset … C when restricted to contacts of index cases receiving intervention within 36 hours of symptom onset … C when restricted to contacts of index cases receiving intervention within 36 hours of symptom onset … : 0% vs. 0% vs. 0% Household contacts Vaccination at least 14 days prior to index case symptom onset:

9. Effect-Dietary-Digestible-Appendix-A (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/effect-dietary-digestible-appendix-a.pdf
   August 31, 2023 - diabetes mellitus/ 531268 3 exp Body Composition/ 198005 4 exp body weight changes/ 226863 5 ("adult onset … type II" or "dm 2" or "insulin independent diabetes" or "ketosis resistant diabetes" or "maturity onset

10. TND-0775-150722 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0775-150722.pdf
    May 12, 2015 - patient characteristics (e.g., age, sex, race, ethnicity, socioeconomic status, time since illness onset … patient characteristics (e.g., age, sex, race, ethnicity, socioeconomic status, time since illness onset … Patient characteristics (e.g., age, sex, race, ethnicity, socioeconomic status, time since illness onset

11. Insomnia Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/insomnia_executive.pdf
    December 01, 2015 - Specific sleep parameters include sleep-onset latency, waking after sleep onset, total sleep time, and … Baseline ISI scores were just over 17 and baseline sleep onset latency was over 45 minutes. … Low-strength evidence showed that zolpidem improved sleep onset latency in older adults. … Moderate-strength evidence showed that wake time after sleep onset improves for older adults. … Few drug trials reported baseline sleep onset latency, total sleep time, wake after sleep onset, or

12. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/ischemic-stroke-treatment_research-protocol.pdf
    February 19, 2010 - treatment of acute ischemic stroke and is currently recommended for use within the first 3 hours of onset … used beyond the 3-hour window.17 Patients who received IV rtPA between 3 and 4.5 hours after stroke onset … specifically evaluated the benefits of IV rtPA administered between 3 and 4.5 hours after symptom onset … 2009 recommending the use of IV rtPA in eligible patients presenting within 3 to 4.5 hours after the onset … ischemic stroke secondary to intracranial large vessel occlusive disease within 8 hours of system onset

13. Lysosomal-Storage-Diseases-Therapies Research-Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/lysosomal-storage-diseases-therapies_research-protocol.pdf
    November 15, 2012 - symptoms of MPS II are highly variable, differing among patients in which symptoms develop, age of onset … As with the other forms of MPS, the following vary among patients: which symptoms develop, age of onset … The clinical characteristics are similar to MPS I, except with a later onset and a slower progression … ) Fabry’s disease, 1/40,000 live male births Fabry’s disease is an X-linked disorder with an onset … The onset of symptoms is variable, from early childhood to late adulthood.

14. Methods Research Report: Linking Evidence Reviews to Organizational Guideline Planning: A Pilot Test of an Interactive Web-Based Presentation and Discussion of Evidence (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/linking-evidence-reviews-methods_0.pdf
    October 01, 2018 - EPC report on pharmacologic and nonpharmacologic treatment of prediabetes to prevent (or delay) the onset … a. first that screening is important, arguably only important because we can prevent/delay the onset … ’s presentation on the evidence for medication and lifestyle interventions to prevent or delay the onset … to make evidence-based guidance on medication and lifestyle interventions to prevent or delay the onset … How effective are lifestyle interventions to delay or prevent the onset of diabetes? a.

15. Disposition of Comments Report for Enzyme-Replacement Therapies for Lysosomal Storage Disease (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/lysosomal-storage-diseases-therapies_disposition-comments.pdf
    January 01, 2014 - Arch Intern Med 2000), although the age of onset can vary markedly. … is a spectrum of disease with differing age of onset and rapidity of progression.” 2. … Change “juvenile/adult” to “late onset”. 1. … Many Pompe patients with “late onset”“juvenile/adult onset” disease have symptoms in early childhood … patients, or in late (non-infantile ) onset patients less than 8 years of age. 2.

16. Interventions To Prevent Age-Related Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer’s-Type Dementia (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cognitive-decline_executive.pdf
    March 01, 2017 - enormous family and societal burdens, identifying interventions with potential to prevent or delay the onset … with Objective To assess the effectiveness of 13 interventions for preventing or delaying the onset … Preventing, slowing, or delaying the onset of MCI? iii. … Preventing, slowing, or delaying the onset of clinical Alzheimer’s-type dementia? a. … The reasons for this are many, including: 1) Meaningful investigation of dementia-onset requires either

17. Interventions To Prevent Age-Related Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer’s-Type Dementia (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/cognitive-decline_executive.pdf
    March 01, 2017 - enormous family and societal burdens, identifying interventions with potential to prevent or delay the onset … with Objective To assess the effectiveness of 13 interventions for preventing or delaying the onset … Preventing, slowing, or delaying the onset of MCI? iii. … Preventing, slowing, or delaying the onset of clinical Alzheimer’s-type dementia? a. … The reasons for this are many, including: 1) Meaningful investigation of dementia-onset requires either

18. Microsoft Word - cognitive-decline-protocol-160322.docx (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/cognitive-decline_research-protocol.pdf
    March 22, 2016 - burdens associated with dementia, identifying interventions with potential to prevent or delay its onset … Association (ADRDA) described criteria in 1983.5 These Alzheimer’s disease criteria describe a gradual onset … We will include a Key Question (KQ) examining the association between the intermediate and the onset … Preventing, slowing, or delaying the onset of MCI? iii. … Preventing, slowing, or delaying the onset of clinical Alzheimer’s-type dementia? a.

19. Intermittent Inhalded Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-194-evidence-summary-corticosteroids-asthma.pdf
    October 01, 2017 - “Quick relief” therapy describes medications used as needed upon onset of symptoms for acute symptom … is the use of ICS and LABA as controller therapy both on a regular basis and on immediate symptom onset … SABA prn at the onset of a URI • Reduces the risk of exacerbation requiring oral corticosteroids (moderate

20. Disposition of Comments_Comparative Effectiveness Review No. 276: Diagnosis and Managment of Obsessive Compulsive Disorders in Children (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/obsessive-compulsive-disorder-disposition-comments.pdf
    December 06, 2024 - criteria] that identified participants with OCD who had concurrent features of pediatric acute- onset … Research: KQ 2 Research planned or in progress, we refer to an ongoing trial of celecoxib in childhood onset